$128.06
1.76%
Nasdaq, Nov 14, 10:00 pm CET
ISIN
US81663L1017
Symbol
WGS

Sema4 Holdings Corp - Ordinary Shares - Class A Stock price

$128.06
+5.95 4.87% 1M
+68.61 115.41% 6M
+51.20 66.61% YTD
+54.33 73.69% 1Y
+98.48 332.96% 3Y
-199.63 60.92% 5Y
-195.34 60.40% 10Y
-195.34 60.40% 20Y
Nasdaq, Closing price Fri, Nov 14 2025
-2.29 1.76%

Key metrics

Basic
Market capitalization
$4.0b
Enterprise Value
$3.9b
Net debt
positive
Cash
$155.1m
Shares outstanding
29.0m
Valuation (TTM | estimate)
P/E
2,134.3 | 74.8
P/S
10.0 | 9.4
EV/Sales
9.7 | 9.2
EV/FCF
261.3
P/B
13.7
Financial Health
Equity Ratio
58.5%
Return on Equity
-21.2%
ROCE
2.5%
ROIC
2.6%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$402.2m | $426.2m
EBITDA
$33.2m | $64.6m
EBIT
$10.0m | $55.9m
Net Income
$2.3m | $49.6m
Free Cash Flow
$15.0m
Growth (TTM | estimate)
Revenue
50.5% | 39.5%
EBITDA
171.9% | 1,392.1%
EBIT
117.3% | 342.8%
Net Income
102.7% | 195.4%
Free Cash Flow
125.1%
Margin (TTM | estimate)
Gross
69.7%
EBITDA
8.3% | 15.2%
EBIT
2.5%
Net
0.6% | 11.6%
Free Cash Flow
3.7%
More
EPS
$0.1
FCF per Share
$0.5
Short interest
24.2%
Employees
1k
Rev per Employee
$310.0k
Show more

Is Sema4 Holdings Corp - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.

Sema4 Holdings Corp - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Sema4 Holdings Corp - Ordinary Shares - Class A forecast:

11x Buy
85%
2x Hold
15%

Analyst Opinions

13 Analysts have issued a Sema4 Holdings Corp - Ordinary Shares - Class A forecast:

Buy
85%
Hold
15%

Financial data from Sema4 Holdings Corp - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
402 402
51% 51%
100%
- Direct Costs 122 122
13% 13%
30%
280 280
76% 76%
70%
- Selling and Administrative Expenses 188 188
23% 23%
47%
- Research and Development Expense 58 58
29% 29%
14%
33 33
172% 172%
8%
- Depreciation and Amortization 23 23
101% 101%
6%
EBIT (Operating Income) EBIT 9.97 9.97
117% 117%
2%
Net Profit 2.27 2.27
103% 103%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Sema4 Holdings Corp - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sema4 Holdings Corp - Ordinary Shares - Class A Stock News

Neutral
The Motley Fool
3 days ago
Sold 69,858 shares, reducing stake value by about $6.45 million Post-trade stake in GeneDx Holdings Corp: zero shares, $0 value The position previously comprised 1.9% of the fund's AUM as of the prior quarter
Neutral
The Motley Fool
5 days ago
Sold 69,858 shares, reducing stake value by about $6.45 million Post-trade stake in GeneDx Holdings Corp: zero shares, $0 value The position previously comprised 1.9% of the fund's AUM as of the prior quarter
Positive
The Motley Fool
6 days ago
Added 120,000 shares of GeneDx Holdings, an increase valued at ~$12.93 million Post-trade stake: 120,000 shares worth $12.93 million as of September 30, 2025 GeneDx Holdings is not among Telemark Asset Management's top five positions by size
More Sema4 Holdings Corp - Ordinary Shares - Class A News

Company Profile

Sema4 Holdings Corp.is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm through its Centrellis health intelligence platform enables to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in 2016 and is headquartered in Stamford, CT.

Head office United States
CEO Katherine Stueland
Employees 1,000
Founded 2015
Website sema4.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today